In recent weeks, PhRMA has amplified a new messaging campaign, including ads and videos such as
“End Middlemen Markups. Put American Patients First.”
These pieces argue that intermediaries in the drug supply chain are driving up costs and suggest that hospitals and safety-net providers may be contributing to the problem.
It’s a compelling narrative, simple, emotional, and easy to digest.
However, it overlooks crucial facts about how drug pricing operates, what drives patient costs, and the vital role of the 340B Drug Pricing Program in supporting vulnerable communities. Read More >
